Research Scientist

The petitioner proposes to develop advanced preclinical cancer models to evaluate the efficacy and immune responses of novel immunotherapies, including cancer vaccines and antibody-drug conjugates. This work focuses on optimizing rational combination strategies to improve clinical outcomes for patients with treatment-resistant and aggressive cancers. The endeavor aims to bridge the gap between laboratory discovery and clinical application to make therapies safer and more accessible.

The petitioner proposes to combine molecular biology methods with innovative drug delivery systems to enhance immune recognition of cancer cells. Her work focuses on developing next-generation immunotherapies that provide highly effective and less toxic treatment options for patients.

The petitioner proposes to engineer immune cells and design tumor-targeting therapies using novel immunotherapy approaches, such as lentiviral systems. The work focuses on developing conditionally dependent peptides that target tumors with high precision to enhance treatment effectiveness. The goal is to create next-generation treatment strategies that reduce cancer relapse and minimize side effects for patients.

The petitioner proposes to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior. Her work focuses on improving the understanding of cancer pathogenesis and immunotherapy to accelerate the development of new therapeutic strategies.